United States (USA) Dialysis Equipments Market Overview, 2031

The dialysis equipment market in the United States is a vital component within the broader landscape of healthcare technology, reflecting changing demands and improvements in renal treatment. This market, which includes a variety of new equipment and technologies, is critical in supporting the treatment of people with renal disorders, facilitating life-sustaining medicines, and increasing quality of life. The United States has a significant burden of kidney illnesses, with chronic kidney disease (CKD) and end-stage renal disease (ESRD) becoming more common. An ageing population, increased rates of diabetes and hypertension (the primary causes of renal disease), and lifestyle-related factors all contribute to this trend. The dialysis equipment market in the United States thrives on technical breakthroughs. Hemodialysis machine, peritoneal dialysis system, hemofiltration device, and portable home dialysis machine advancements have improved treatment efficacy, patient comfort, and accessibility to dialysis therapies. These improvements attempt to enhance outcomes, streamline operations, and provide more personalised treatment. The growing use of home-based dialysis therapy is a prominent trend in the US dialysis equipment market. Patients who choose home hemodialysis (HHD) or peritoneal dialysis (PD) want more freedom, independence, and a higher quality of life. This tendency is being met by portable and user-friendly gadgets, which allow patients to receive treatments in the comfort of their own homes. The economic environment has a considerable impact on the dialysis equipment market.


According to the research report, "US Dialysis Equipments Market Outlook, 2031," published by Bonafide Research, the US Dialysis Equipments Market is anticipated to grow at more than 4.94% CAGR from 2026 to 2031.The high cost of dialysis treatments, as well as government initiatives and insurance coverage for renal care, have an impact on the acceptance and availability of sophisticated dialysis equipment. In this setting, cost-effective and efficient technologies take centre stage. In the United States, the dialysis equipment market is governed by a complex healthcare reimbursement framework. Government initiatives, like Medicare, have a huge impact on market dynamics by covering a significant amount of qualifying patients' dialysis costs. Manufacturers and healthcare providers must negotiate this terrain to ensure the affordability and accessibility of renal care for patients. There are over 500,000 dialysis patients in the United States, and the number is growing at a significant rate, boosting the demand for dialysis equipment. Based on product type market is divided into hemodialysis devices, peritoneal dialysis equipment and others. Among them market is majorly dominated by hemodialysis devices with significant market share. In the United States, hemodialysis is the most commonly used kind of renal replacement therapy. As of its extensive availability and long history in the country, hemodialysis is the first choice for the majority of patients with end-stage renal disease (ESRD). The United States has a broad network of dialysis centres that mostly provide in-centre hemodialysis treatments. Because these facilities are outfitted with hemodialysis machines and specialised staff, in-centre hemodialysis is a handy and accessible option for many patients.

In the United States dialysis equipment market, product segmentation is led decisively by hemodialysis devices, which remain the most widely used and clinically dominant solution for renal replacement therapy. Hemodialysis devices are extensively deployed due to their long standing clinical acceptance, high treatment efficiency, and suitability for managing patients with advanced or complex kidney failure who require close medical supervision. These devices are supported by a mature ecosystem that includes sophisticated machines, dialyzers, bloodlines, and advanced water treatment systems, making them the preferred choice in structured care settings. The high prevalence of chronic kidney disease combined with strong reimbursement coverage and established treatment protocols reinforces continued reliance on hemodialysis equipment. Frequent technology upgrades such as automated fluid management, real time monitoring, and enhanced safety features further strengthen demand, as providers prioritize treatment accuracy, patient safety, and operational efficiency. Peritoneal dialysis equipment, while smaller in overall share, represents a rapidly expanding segment driven by increasing acceptance of home based therapy and patient preference for flexible treatment schedules. Automated peritoneal dialysis systems and disposable consumables are gaining traction due to ease of use and reduced dependency on facility visits, particularly among stable patients. The others category, which includes accessories, monitoring systems, and supportive devices, plays a complementary but essential role by enhancing treatment effectiveness and supporting both hemodialysis and peritoneal modalities.

Dialysis centers and hospitals clearly dominate the United States dialysis equipment market, reflecting the country’s strong reliance on facility based renal care for managing chronic and end stage kidney disease. These settings handle the majority of dialysis treatments, particularly hemodialysis, which requires specialized equipment, trained professionals, and continuous patient monitoring. Dialysis centers and hospitals are equipped with advanced infrastructure including water purification systems, emergency response capabilities, and digital monitoring platforms that ensure consistent treatment quality and compliance with clinical standards. High patient volumes and frequent treatment schedules result in substantial demand for dialysis machines and consumables, making these facilities the largest purchasers and users of dialysis equipment. Strong insurance coverage and reimbursement frameworks further support in center treatment utilization, enabling patients to access care without prohibitive out of pocket costs. Home healthcare, while currently smaller in market share, is the fastest growing end user segment as patient preferences and care models evolve. Home dialysis adoption is increasing due to improved device portability, simplified operation, and remote monitoring technologies that allow clinicians to oversee treatment outside traditional facilities. Patients benefit from greater flexibility, reduced travel burden, and improved quality of life, while healthcare systems benefit from reduced facility congestion and long term cost efficiency.

"Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031
Aspects covered in this report
• Insulin Delivery Devices Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation



By Product Type
• Hemodialysia Devices
• Peritoneal Dialysis Equipment
• Others

By End User
• Dialysis Centers and Hospitals
• Home Healthcare